| Size & multiples | |||
| Market Cap | $2.21B | Enterprise Value | $2.59B |
| P/E (TTM) | 13.85× | PEG (trailing) | 0.40× |
| P/S | 1.14× | P/FCF | — |
| EV/EBITDA | 10.75× | EV/EBIT | 11.86× |
| EV/Sales | 1.34× | EV/FCF | — |
| FCF Yield | — | Buyback Yield | 4.83% |
| Owner Earnings Yield | — | Shareholder Yield | — |
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.64 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 7.22% |
| After-tax Cost of Debt | 4.54% | Synthetic credit rating | A |
| Cost of Debt · embedded (pre-tax) | 5.94% | Cost of Debt · marginal (synthetic) | 4.78% |
| WACC | 6.65% | ROIC | 14.24% |
| EVA Spread (ROIC−WACC) | 7.59% | EVA | $82.6M |
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $1.94 · revenue TTM $1.93B · FCF TTM —
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Cheap vs Health Care on P/E, EV/EBITDA
P/E 28th · EV/EBITDA 29th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 13.8x | 24.4x | 13.0x–39.3x | 28 ↓cheap |
| EV/EBITDA | 10.6x | 15.1x | 9.8x–24.4x | 29 ↓cheap |
| Net Margin | 8.6% | -21.2% | -325.3%–7.2% | 78 ↑strong |
| Operating Margin | 10.9% | -34.5% | -552.0%–8.0% | 79 ↑strong |
| ROE | 20.3% | -36.8% | -92.5%–4.5% | 90 ↑strong |
